Roche Partners With Hansoh in Deal That Could Exceed $15 Billion
Roche Holding entered a collaboration and licensing agreement with China's Hansoh Pharmaceutical Group. Hansoh will receive $400 million upfront and $110 million after a year, with eligibility for potential additional payments.
Roche Holding has signed a collaboration and licensing agreement with China’s Hansoh Pharmaceutical Group in a deal that could exceed $15 billion. Under the agreement, Hansoh will receive $400 million upfront and another $110 million after a year. It will also be eligible for potential payments…